Oncolines

Oncolines is a specialized contract research organization (CRO) and precision medicine company based in the Netherlands that focuses on oncology and immunotherapy drug discovery. The company provides a high-quality cell line profiling platform, featuring a panel of over 200 human cancer cell lines to characterize the potency and selectivity of novel anti-cancer agents. Their services include mechanistic studies, drug combination testing, and biomarker identification to support the development of both small molecules and biologics. By integrating extensive genomic data with advanced bioinformatics, Oncolines assists pharmaceutical and biotech clients in predicting clinical responses and optimizing lead compounds. As part of the Symeres group, Oncolines leverages deep expertise in translational research to accelerate the path from discovery to the clinic.